Newsletter – September 15th 2022
In Vitro Testing of Dry Powder Nasal Delivery Devices Successful nasal drug delivery of dry powder formulations requires a delivered dose that can penetrate beyond
Menu
Your CDMO Specialist
Supporting You From Feasibility To Clinic
Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
We offer our clients an extensive range of services, from early feasibility to dosage form development and clinical trial manufacturing.
Pre-Formulation Studies
Upperton’s formulation development team will confidently guide you on the best route forward.
Formulation Development
Utilise our expertise and know-how to solve problems unique to your challenging molecule.
Clinical Manufaturing
FIH through to phase II clinical
manufacturing. No project is too small or too challenging.
Can we help you?
Latest news
Newsletter – August 16th 2022
Latest News from Upperton Pharma Solutions Successful MHRA Inspection Upperton is delighted to announce that during the last week of July 2022 the UK MHRA
Newsletter – June 23rd 2022
Characterising the physical properties of spray dried powders The benefits of powder characterisation When developing products containing spray dried powders it is vital that the